Skip to main content

Published locations for IDWEEK: Cefazolin beats ceftriaxone for MSSA bacteremia treatment

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. IDWEEK: Cefazolin beats ceftriaxone for MSSA bacteremia treatment

User login

  • Reset your password
  • /content/idweek-cefazolin-beats-ceftriaxone-mssa-bacteremia-treatment
  • /emed-journal/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats-ceftriaxone-mssa
  • /familypracticenews/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats-ceftriaxone
  • /ehospitalistnews/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats-ceftriaxone
  • /idpractitioner/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats-ceftriaxone-mssa
  • /internalmedicinenews/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats
  • /infectiousdisease/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats-ceftriaxone
  • /internalmedicine/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats-ceftriaxone
  • /familymedicine/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats-ceftriaxone-mssa
  • /emergencymedicine/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats-ceftriaxone
  • /chestphysician/article/105143/healthcare-acquired-infections/idweek-cefazolin-beats-ceftriaxone-mssa